Summary
Biogen Idec Inc. (BIIB) filed a Form 8-K on January 31, 2012, to report its financial results for the full year and fourth quarter ended December 31, 2011. This filing primarily served as a vehicle to furnish a press release detailing these operational and financial outcomes. Investors should note that the information provided in the press release, while significant for understanding the company's performance, is furnished and not deemed 'filed' under Section 18 of the Exchange Act, meaning it doesn't carry the same legal implications as a formally filed document. The key takeaway for investors is that this 8-K is an announcement of financial performance. Investors interested in the specific financial figures, such as revenue, earnings per share, and any forward-looking guidance provided in the press release, would need to review Exhibit 99, the press release itself. This filing indicates the company is adhering to its reporting obligations by disseminating its financial results to the public.
Key Highlights
- 1Biogen Idec reported its financial results for the full year and fourth quarter of 2011.
- 2The report was filed on January 31, 2012, coinciding with the earnings release date.
- 3The primary purpose of the 8-K was to furnish a press release containing the financial and operational results.
- 4Exhibit 99 contains the full press release with the detailed financial information.
- 5The furnished press release is not considered 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.
- 6This filing provides investors with an official notification of the company's recent financial performance.